BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR-1.6%
5Y CAGR+7.0%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-1.6%/yr
vs +0.0%/yr prior
5Y CAGR
+7.0%/yr
Recent deceleration
Acceleration
-1.7pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202512.87%
202417.97%
202315.42%
202213.53%
2021-0.76%
20209.18%
201914.27%
201813.52%
201717.62%
201625.50%